NCT05873725View on ClinicalTrials.gov

Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin

Active, not recruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

May 20, 2023

Primary Completion Date

September 30, 2023

Study Completion Date

May 31, 2024

Conditions
IVFInfertility
Interventions
DRUG

Follitropin delta

Evaluation of the IVF cycle using the prescribed medication

Trial Locations (1)

H4P 2S4

Clinique Ovo, Montreal

Sponsors

Lead Sponsor

Clinique Ovo
All Listed Sponsors
lead

Clinique Ovo

INDUSTRY

NCT05873725 - Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin | Biotech Hunter | Biotech Hunter